Global Active Pharmaceutical Ingredients Market Professional Survey Report 2016
This report mainly covers the following
Product types including
Data including (both global and regions): Market Size (both volume - MT and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/MT, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
Product types including
- Anti infective Drugs
- Respiratory system drugs
- Vitamins
- Central nervous system drugs
- Antihistamines and antidote
- Antiseptic treatment
- Hormones
- Nourishing medicine
- USA
- Europe
- Japan
- China
- India
- Teva Active Pharmaceutical Industries Limited
- DSM
- Novartis
- Roche
- Johnson & Johnson
- Dr. Reddy’s
- Pfizer
- Bayer
- BASF
- Cambrex
- Sun Pharmaceutical Industries
- Lonza group
- Boehringer Ingelheim GmbH
- Aurobindo pharma
- Lupin
- Biocon
- Cipla
- Hisun Pharmacy
- Huahai Pharmaceutical
- North China Pharmaceutical Group
- Shandong Lukang Pharmaceutical Co., Ltd
- Haerbin Pharmaceutical Group
- Shandong Xinhua Pharmaceutical Co.,Ltd
- Jiangsu Hengrui Medicine
- Tian Yao
- North East Pharmaceutical
- Zhejiang Medicine
Data including (both global and regions): Market Size (both volume - MT and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/MT, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 INDUSTRY OVERVIEW OF ACTIVE PHARMACEUTICAL INGREDIENTS
1.1 Definition and Specifications of Active Pharmaceutical Ingredients
1.1.1 Definition of Active Pharmaceutical Ingredients
1.1.2 Specifications of Active Pharmaceutical Ingredients
1.2 Classification of Active Pharmaceutical Ingredients
1.2.1 Anti infective Drugs
1.2.2 Respiratory system drugs
1.2.3 Vitamins
1.2.4 Central nervous system drugs
1.2.5 Antihistamines and antidote
1.2.6 Antiseptic treatment
1.2.7 Hormones
1.2.8 Nourishing medicine
1.3 Applications of Active Pharmaceutical Ingredients
1.4 Industry Chain Structure of Active Pharmaceutical Ingredients
1.5 Industry Overview and Major Regions Status of Active Pharmaceutical Ingredients
1.5.1 Industry Overview of Active Pharmaceutical Ingredients
1.5.2 Global Major Regions Status of Active Pharmaceutical Ingredients
1.6 Industry Policy Analysis of Active Pharmaceutical Ingredients
1.7 Industry News Analysis of Active Pharmaceutical Ingredients
2 MANUFACTURING COST STRUCTURE ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
2.1 Raw Material Suppliers and Price Analysis of Active Pharmaceutical Ingredients
2.2 Equipment Suppliers and Price Analysis of Active Pharmaceutical Ingredients
2.3 Labor Cost Analysis of Active Pharmaceutical Ingredients
2.4 Other Costs Analysis of Active Pharmaceutical Ingredients
2.5 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredients
2.6 Manufacturing Process Analysis of Active Pharmaceutical Ingredients
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
3.1 Capacity and Commercial Production Date of Global Active Pharmaceutical Ingredients Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Active Pharmaceutical Ingredients Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Active Pharmaceutical Ingredients Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Active Pharmaceutical Ingredients Major Manufacturers in 2015
4 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS OVERALL MARKET OVERVIEW
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Active Pharmaceutical Ingredients Capacity and Growth Rate Analysis
4.2.2 2015 Active Pharmaceutical Ingredients Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Active Pharmaceutical Ingredients Sales and Growth Rate Analysis
4.3.2 2015 Active Pharmaceutical Ingredients Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Active Pharmaceutical Ingredients Sales Price
4.4.2 2015 Active Pharmaceutical Ingredients Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Active Pharmaceutical Ingredients Gross Margin
4.5.2 2015 Active Pharmaceutical Ingredients Gross Margin Analysis (Company Segment)
5 ACTIVE PHARMACEUTICAL INGREDIENTS REGIONAL MARKET ANALYSIS
5.1 USA Active Pharmaceutical Ingredients Market Analysis
5.1.1 USA Active Pharmaceutical Ingredients Market Overview
5.1.2 USA 2011-2016E Active Pharmaceutical Ingredients Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E Active Pharmaceutical Ingredients Sales Price Analysis
5.1.4 USA 2015 Active Pharmaceutical Ingredients Market Share Analysis
5.2 Europe Active Pharmaceutical Ingredients Market Analysis
5.2.1 Europe Active Pharmaceutical Ingredients Market Overview
5.2.2 Europe 2011-2016E Active Pharmaceutical Ingredients Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Active Pharmaceutical Ingredients Sales Price Analysis
5.2.4 Europe 2015 Active Pharmaceutical Ingredients Market Share Analysis
5.3 Japan Active Pharmaceutical Ingredients Market Analysis
5.3.1 Japan Active Pharmaceutical Ingredients Market Overview
5.3.2 Japan 2011-2016E Active Pharmaceutical Ingredients Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Japan 2011-2016E Active Pharmaceutical Ingredients Sales Price Analysis
5.3.4 Japan 2015 Active Pharmaceutical Ingredients Market Share Analysis
5.4 China Active Pharmaceutical Ingredients Market Analysis
5.4.1 China Active Pharmaceutical Ingredients Market Overview
5.4.2 China 2011-2016E Active Pharmaceutical Ingredients Local Supply, Import, Export, Local Consumption Analysis
5.4.3 China 2011-2016E Active Pharmaceutical Ingredients Sales Price Analysis
5.4.4 China 2015 Active Pharmaceutical Ingredients Market Share Analysis
5.5 India Active Pharmaceutical Ingredients Market Analysis
5.5.1 India Active Pharmaceutical Ingredients Market Overview
5.5.2 India 2011-2016E Active Pharmaceutical Ingredients Local Supply, Import, Export, Local Consumption Analysis
5.5.3 India 2011-2016E Active Pharmaceutical Ingredients Sales Price Analysis
5.5.4 India 2015 Active Pharmaceutical Ingredients Market Share Analysis
6 GLOBAL 2011-2016E ACTIVE PHARMACEUTICAL INGREDIENTS SEGMENT MARKET ANALYSIS (BY TYPE)
6.1 Global 2011-2016E Active Pharmaceutical Ingredients Sales by Type
6.2 Different Types Active Pharmaceutical Ingredients Product Interview Price Analysis
6.3 Different Types Active Pharmaceutical Ingredients Product Driving Factors Analysis
6.3.1 Anti infective Drugs Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.2 Respiratory system drugs Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.3 Vitamins Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.4 Central nervous system drugs Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.5 Antihistamines and antidote Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.6 Antiseptic treatment Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.7 Hormones Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.8 Nourishing medicine Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.9 Active Pharmaceutical Ingredients Growth Driving Factor Analysis
7 GLOBAL 2011-2016E ACTIVE PHARMACEUTICAL INGREDIENTS SEGMENT MARKET ANALYSIS (BY APPLICATION)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
8 MAJOR MANUFACTURERS ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
8.1 Teva Active Pharmaceutical Industries Limited
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Teva Active Pharmaceutical Industries Limited 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Teva Active Pharmaceutical Industries Limited 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.2 DSM
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 DSM 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 DSM 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.3 Novartis
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Novartis 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Novartis 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.4 Roche
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Roche 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Roche 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.5 Johnson & Johnson
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Johnson & Johnson 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Johnson & Johnson 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.6 Dr. Reddy’s
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Dr. Reddy’s 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Dr. Reddy’s 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.7 Pfizer
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Pfizer 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Pfizer 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.8 Bayer
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Bayer 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Bayer 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.9 BASF
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 BASF 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 BASF 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.10 Cambrex
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Cambrex 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Cambrex 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.11 Sun Pharmaceutical Industries
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Sun Pharmaceutical Industries 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Sun Pharmaceutical Industries 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.12 Lonza group
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Lonza group 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Lonza group 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.13 Boehringer Ingelheim GmbH
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Boehringer Ingelheim GmbH 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Boehringer Ingelheim GmbH 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.14 Aurobindo pharma
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Aurobindo pharma 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Aurobindo pharma 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.15 Lupin
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Lupin 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Lupin 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.16 Biocon
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Biocon 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Biocon 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.17 Cipla
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Cipla 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Cipla 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.18 Hisun Pharmacy
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Hisun Pharmacy 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Hisun Pharmacy 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.19 Huahai Pharmaceutical
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 Huahai Pharmaceutical 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 Huahai Pharmaceutical 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.20 North China Pharmaceutical Group
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.3 North China Pharmaceutical Group 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 North China Pharmaceutical Group 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.21 Shandong Lukang Pharmaceutical Co., Ltd
8.21.1 Company Profile
8.21.2 Product Picture and Specifications
8.21.3 Shandong Lukang Pharmaceutical Co., Ltd 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.21.4 Shandong Lukang Pharmaceutical Co., Ltd 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.22 Haerbin Pharmaceutical Group
8.22.1 Company Profile
8.22.2 Product Picture and Specifications
8.22.3 Haerbin Pharmaceutical Group 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.22.4 Haerbin Pharmaceutical Group 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.23 Shandong Xinhua Pharmaceutical Co.,Ltd
8.23.1 Company Profile
8.23.2 Product Picture and Specifications
8.23.3 Shandong Xinhua Pharmaceutical Co.,Ltd 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.23.4 Shandong Xinhua Pharmaceutical Co.,Ltd 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.24 Jiangsu Hengrui Medicine
8.24.1 Company Profile
8.24.2 Product Picture and Specifications
8.24.3 Jiangsu Hengrui Medicine 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.24.4 Jiangsu Hengrui Medicine 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.25 Tian Yao
8.25.1 Company Profile
8.25.2 Product Picture and Specifications
8.25.3 Tian Yao 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.25.4 Tian Yao 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.26 North East Pharmaceutical
8.26.1 Company Profile
8.26.2 Product Picture and Specifications
8.26.3 North East Pharmaceutical 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.26.4 North East Pharmaceutical 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.27 Zhejiang Medicine
8.27.1 Company Profile
8.27.2 Product Picture and Specifications
8.27.3 Zhejiang Medicine 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.27.4 Zhejiang Medicine 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
9 DEVELOPMENT TREND OF ANALYSIS OF MARKET
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 Active Pharmaceutical Ingredients Consumption Forecast
9.2.2 Europe 2016-2021 Active Pharmaceutical Ingredients Consumption Forecast
9.2.3 Japan 2016-2021 Active Pharmaceutical Ingredients Consumption Forecast
9.2.4 China 2016-2021 Active Pharmaceutical Ingredients Consumption Forecast
9.2.5 India 2016-2021 Active Pharmaceutical Ingredients Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 ACTIVE PHARMACEUTICAL INGREDIENTS MARKETING MODEL ANALYSIS
10.1 Active Pharmaceutical Ingredients Regional Marketing Model Analysis
10.2 Active Pharmaceutical Ingredients International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Active Pharmaceutical Ingredients by Regions
10.4 Active Pharmaceutical Ingredients Supply Chain Analysis
11 CONSUMERS ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
12.1 New Project SWOT Analysis of Active Pharmaceutical Ingredients
12.2 New Project Investment Feasibility Analysis of Active Pharmaceutical Ingredients
13 CONCLUSION OF THE GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET PROFESSIONAL SURVEY REPORT 2016
1.1 Definition and Specifications of Active Pharmaceutical Ingredients
1.1.1 Definition of Active Pharmaceutical Ingredients
1.1.2 Specifications of Active Pharmaceutical Ingredients
1.2 Classification of Active Pharmaceutical Ingredients
1.2.1 Anti infective Drugs
1.2.2 Respiratory system drugs
1.2.3 Vitamins
1.2.4 Central nervous system drugs
1.2.5 Antihistamines and antidote
1.2.6 Antiseptic treatment
1.2.7 Hormones
1.2.8 Nourishing medicine
1.3 Applications of Active Pharmaceutical Ingredients
1.4 Industry Chain Structure of Active Pharmaceutical Ingredients
1.5 Industry Overview and Major Regions Status of Active Pharmaceutical Ingredients
1.5.1 Industry Overview of Active Pharmaceutical Ingredients
1.5.2 Global Major Regions Status of Active Pharmaceutical Ingredients
1.6 Industry Policy Analysis of Active Pharmaceutical Ingredients
1.7 Industry News Analysis of Active Pharmaceutical Ingredients
2 MANUFACTURING COST STRUCTURE ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
2.1 Raw Material Suppliers and Price Analysis of Active Pharmaceutical Ingredients
2.2 Equipment Suppliers and Price Analysis of Active Pharmaceutical Ingredients
2.3 Labor Cost Analysis of Active Pharmaceutical Ingredients
2.4 Other Costs Analysis of Active Pharmaceutical Ingredients
2.5 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredients
2.6 Manufacturing Process Analysis of Active Pharmaceutical Ingredients
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
3.1 Capacity and Commercial Production Date of Global Active Pharmaceutical Ingredients Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Active Pharmaceutical Ingredients Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Active Pharmaceutical Ingredients Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Active Pharmaceutical Ingredients Major Manufacturers in 2015
4 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS OVERALL MARKET OVERVIEW
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Active Pharmaceutical Ingredients Capacity and Growth Rate Analysis
4.2.2 2015 Active Pharmaceutical Ingredients Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Active Pharmaceutical Ingredients Sales and Growth Rate Analysis
4.3.2 2015 Active Pharmaceutical Ingredients Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Active Pharmaceutical Ingredients Sales Price
4.4.2 2015 Active Pharmaceutical Ingredients Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Active Pharmaceutical Ingredients Gross Margin
4.5.2 2015 Active Pharmaceutical Ingredients Gross Margin Analysis (Company Segment)
5 ACTIVE PHARMACEUTICAL INGREDIENTS REGIONAL MARKET ANALYSIS
5.1 USA Active Pharmaceutical Ingredients Market Analysis
5.1.1 USA Active Pharmaceutical Ingredients Market Overview
5.1.2 USA 2011-2016E Active Pharmaceutical Ingredients Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E Active Pharmaceutical Ingredients Sales Price Analysis
5.1.4 USA 2015 Active Pharmaceutical Ingredients Market Share Analysis
5.2 Europe Active Pharmaceutical Ingredients Market Analysis
5.2.1 Europe Active Pharmaceutical Ingredients Market Overview
5.2.2 Europe 2011-2016E Active Pharmaceutical Ingredients Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Active Pharmaceutical Ingredients Sales Price Analysis
5.2.4 Europe 2015 Active Pharmaceutical Ingredients Market Share Analysis
5.3 Japan Active Pharmaceutical Ingredients Market Analysis
5.3.1 Japan Active Pharmaceutical Ingredients Market Overview
5.3.2 Japan 2011-2016E Active Pharmaceutical Ingredients Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Japan 2011-2016E Active Pharmaceutical Ingredients Sales Price Analysis
5.3.4 Japan 2015 Active Pharmaceutical Ingredients Market Share Analysis
5.4 China Active Pharmaceutical Ingredients Market Analysis
5.4.1 China Active Pharmaceutical Ingredients Market Overview
5.4.2 China 2011-2016E Active Pharmaceutical Ingredients Local Supply, Import, Export, Local Consumption Analysis
5.4.3 China 2011-2016E Active Pharmaceutical Ingredients Sales Price Analysis
5.4.4 China 2015 Active Pharmaceutical Ingredients Market Share Analysis
5.5 India Active Pharmaceutical Ingredients Market Analysis
5.5.1 India Active Pharmaceutical Ingredients Market Overview
5.5.2 India 2011-2016E Active Pharmaceutical Ingredients Local Supply, Import, Export, Local Consumption Analysis
5.5.3 India 2011-2016E Active Pharmaceutical Ingredients Sales Price Analysis
5.5.4 India 2015 Active Pharmaceutical Ingredients Market Share Analysis
6 GLOBAL 2011-2016E ACTIVE PHARMACEUTICAL INGREDIENTS SEGMENT MARKET ANALYSIS (BY TYPE)
6.1 Global 2011-2016E Active Pharmaceutical Ingredients Sales by Type
6.2 Different Types Active Pharmaceutical Ingredients Product Interview Price Analysis
6.3 Different Types Active Pharmaceutical Ingredients Product Driving Factors Analysis
6.3.1 Anti infective Drugs Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.2 Respiratory system drugs Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.3 Vitamins Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.4 Central nervous system drugs Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.5 Antihistamines and antidote Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.6 Antiseptic treatment Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.7 Hormones Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.8 Nourishing medicine Active Pharmaceutical Ingredients Growth Driving Factor Analysis
6.3.9 Active Pharmaceutical Ingredients Growth Driving Factor Analysis
7 GLOBAL 2011-2016E ACTIVE PHARMACEUTICAL INGREDIENTS SEGMENT MARKET ANALYSIS (BY APPLICATION)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
8 MAJOR MANUFACTURERS ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
8.1 Teva Active Pharmaceutical Industries Limited
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Teva Active Pharmaceutical Industries Limited 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Teva Active Pharmaceutical Industries Limited 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.2 DSM
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 DSM 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 DSM 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.3 Novartis
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Novartis 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Novartis 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.4 Roche
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Roche 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Roche 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.5 Johnson & Johnson
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Johnson & Johnson 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Johnson & Johnson 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.6 Dr. Reddy’s
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Dr. Reddy’s 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Dr. Reddy’s 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.7 Pfizer
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Pfizer 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Pfizer 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.8 Bayer
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Bayer 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Bayer 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.9 BASF
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 BASF 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 BASF 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.10 Cambrex
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Cambrex 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Cambrex 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.11 Sun Pharmaceutical Industries
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Sun Pharmaceutical Industries 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Sun Pharmaceutical Industries 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.12 Lonza group
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Lonza group 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Lonza group 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.13 Boehringer Ingelheim GmbH
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Boehringer Ingelheim GmbH 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Boehringer Ingelheim GmbH 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.14 Aurobindo pharma
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Aurobindo pharma 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Aurobindo pharma 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.15 Lupin
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Lupin 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Lupin 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.16 Biocon
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Biocon 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Biocon 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.17 Cipla
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Cipla 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Cipla 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.18 Hisun Pharmacy
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Hisun Pharmacy 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Hisun Pharmacy 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.19 Huahai Pharmaceutical
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 Huahai Pharmaceutical 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 Huahai Pharmaceutical 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.20 North China Pharmaceutical Group
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.3 North China Pharmaceutical Group 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 North China Pharmaceutical Group 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.21 Shandong Lukang Pharmaceutical Co., Ltd
8.21.1 Company Profile
8.21.2 Product Picture and Specifications
8.21.3 Shandong Lukang Pharmaceutical Co., Ltd 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.21.4 Shandong Lukang Pharmaceutical Co., Ltd 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.22 Haerbin Pharmaceutical Group
8.22.1 Company Profile
8.22.2 Product Picture and Specifications
8.22.3 Haerbin Pharmaceutical Group 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.22.4 Haerbin Pharmaceutical Group 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.23 Shandong Xinhua Pharmaceutical Co.,Ltd
8.23.1 Company Profile
8.23.2 Product Picture and Specifications
8.23.3 Shandong Xinhua Pharmaceutical Co.,Ltd 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.23.4 Shandong Xinhua Pharmaceutical Co.,Ltd 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.24 Jiangsu Hengrui Medicine
8.24.1 Company Profile
8.24.2 Product Picture and Specifications
8.24.3 Jiangsu Hengrui Medicine 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.24.4 Jiangsu Hengrui Medicine 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.25 Tian Yao
8.25.1 Company Profile
8.25.2 Product Picture and Specifications
8.25.3 Tian Yao 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.25.4 Tian Yao 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.26 North East Pharmaceutical
8.26.1 Company Profile
8.26.2 Product Picture and Specifications
8.26.3 North East Pharmaceutical 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.26.4 North East Pharmaceutical 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
8.27 Zhejiang Medicine
8.27.1 Company Profile
8.27.2 Product Picture and Specifications
8.27.3 Zhejiang Medicine 2015 Active Pharmaceutical Ingredients Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.27.4 Zhejiang Medicine 2015 Active Pharmaceutical Ingredients Business Region Distribution Analysis
9 DEVELOPMENT TREND OF ANALYSIS OF MARKET
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 Active Pharmaceutical Ingredients Consumption Forecast
9.2.2 Europe 2016-2021 Active Pharmaceutical Ingredients Consumption Forecast
9.2.3 Japan 2016-2021 Active Pharmaceutical Ingredients Consumption Forecast
9.2.4 China 2016-2021 Active Pharmaceutical Ingredients Consumption Forecast
9.2.5 India 2016-2021 Active Pharmaceutical Ingredients Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 ACTIVE PHARMACEUTICAL INGREDIENTS MARKETING MODEL ANALYSIS
10.1 Active Pharmaceutical Ingredients Regional Marketing Model Analysis
10.2 Active Pharmaceutical Ingredients International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Active Pharmaceutical Ingredients by Regions
10.4 Active Pharmaceutical Ingredients Supply Chain Analysis
11 CONSUMERS ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS
12.1 New Project SWOT Analysis of Active Pharmaceutical Ingredients
12.2 New Project Investment Feasibility Analysis of Active Pharmaceutical Ingredients
13 CONCLUSION OF THE GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET PROFESSIONAL SURVEY REPORT 2016
